Educational Activities Archives

Join us for this evidence-based course that cuts through the confusion, dispels longstanding myths, and gives you the practical knowledge to make confident, compassionate treatment decisions. You will leave with a clear understanding of when and how to use buprenorphine or methadone, how to employ shared-decision making with patients through the realities of neonatal withdrawal, and how to build a postpartum care plan that supports both mother and child long after delivery. Whether you are new to this patient population or looking to sharpen your clinical approach, this course meets you where you are and empowers you to do more.

Join our 4-session online case-based learning collaborative series focused on treating opioid use disorder. Delve into best practices on OUD and Pregnancy and explore real-world cases provided by addiction experts, applying knowledge to practical situations. Each session is presented live online and spans 1.5 hours.

View Guidance.

Opioid use disorder (OUD) can be a fatal addiction with complex implications for new and/or expecting mothers. OUD challenges can lead to many complications for mother and child, including low birth weight, clinical challenges with medical dosing and increased risk of accidental death. In the U.S. alone, a baby is born passively dependent every 15 minutes. To ensure best health outcomes for both mother and child, policies must allow engagement in evidence-based treatment and protect clients from legal ramifications. Hear from a physician, clinic director and an individual with lived experience to broaden understandings about the treatment and policy landscape for pregnant and postpartum women with OUD.

“The purpose of this checklist is for the dental patient (or guardian) and the dental provider to review their roles and responsibilities for safely using, storing, and disposing of opioid (or other controlled substance) prescriptions. A controlled substance is a medication or other drug that the United States Drug Enforcement Administration (DEA) has identified as having a high potential for misuse, addiction and/or dependency.”

“Discussing pain medications with your patients is important to ensure they understand the options to manage their pain. It is important to provide clear and consistent guidance, whether your patient has a history of substance use disorders, may be taking opioids for the first time, or may be at higher risk for misuse or overdose. Treatment of a patient’s pain should be personalized, multidisciplinary, and patient-centered.”